Memantine prevents memory consolidation failure induced by soluble beta amyloid in rats.

作者: Paolo Tucci , Emanuela Mhillaj , Maria Grazia Morgese , Marilena Colaianna , Margherita Zotti

DOI: 10.3389/FNBEH.2014.00332

关键词:

摘要: It has been well documented that β-amyloid peptide accumulation and aggregation in the brain plays a crucial role pathophysiology of Alzheimer’s disease (AD). However, new orientation amyloid cascade hypothesis evidenced soluble forms (sAβ) are involved Aβ-induced cognitive impairment cause rapid disruption synaptic mechanisms underlying memory. The primary aim this study was to elucidate effects sAβ, acutely injected intracerebrally (i.c.v., 4 µM), on short term long memory young adult male rats, by using novel object recognition task. Glutamatergic receptors have proposed as mediating effect Aβ plasticity Thus, we also investigated sAβ prefrontal cortex (PFC) glutamate release specific contribution N-methyl-D-aspartate (NMDA) receptor modulation administration parameters evaluated. We found single i.c.v. injection 2h before testing did not alter ability rats differentiate between familiar object, test, while it able negatively affect consolidation/retrieval Moreover, significant increase levels PFC treated with 2 h earlier. Interestingly, deficit induced reversed NMDA-receptor antagonist, memantine (5 mg/kg i.p), administered immediately after familiarization trial (T1). On contrary, 30 min T1 trial, rescue impairment. Taken together, our results suggest an acute interferes such sAβ-induced indicates involvement glutamatergic system, proposing NMDA inhibition might prevent or lead recovery early

参考文章(72)
Chris G. Parsons, Kate Gilling, Memantine as an example of a fast, voltage-dependent, open channel N-methyl-D-aspartate receptor blocker. Methods of Molecular Biology. ,vol. 403, pp. 15- 36 ,(2007) , 10.1007/978-1-59745-529-9_2
Panteleimon Giannakopoulos, Enikö Kövari, Gabriel Gold, Armin von Gunten, Patrick R. Hof, Constantin Bouras, Pathological substrates of cognitive decline in Alzheimer's disease. Frontiers of neurology and neuroscience. ,vol. 24, pp. 20- 29 ,(2009) , 10.1159/000197881
M Colaianna, P Tucci, M Zotti, MG Morgese, S Schiavone, S Govoni, V Cuomo, L Trabace, Soluble βamyloid1-42: a critical player in producing behavioural and biochemical changes evoking depressive-related state? British Journal of Pharmacology. ,vol. 159, pp. 1704- 1715 ,(2010) , 10.1111/J.1476-5381.2010.00669.X
Kyle C. Wilcox, Pascale N. Lacor, Jason Pitt, William L. Klein, Aβ oligomer-induced synapse degeneration in Alzheimer's disease. Cellular and Molecular Neurobiology. ,vol. 31, pp. 939- 948 ,(2011) , 10.1007/S10571-011-9691-4
I. Klyubin, V. Betts, A. T. Welzel, K. Blennow, H. Zetterberg, A. Wallin, C. A. Lemere, W. K. Cullen, Y. Peng, T. Wisniewski, D. J. Selkoe, R. Anwyl, D. M. Walsh, M. J. Rowan, Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization. The Journal of Neuroscience. ,vol. 28, pp. 4231- 4237 ,(2008) , 10.1523/JNEUROSCI.5161-07.2008
Leonard Berg, Daniel W. McKeel, J. Philip Miller, Martha Storandt, Eugene H. Rubin, John C. Morris, Jack Baty, Mary Coats, Joanne Norton, Alison M. Goate, Joseph L. Price, Marla Gearing, Suzanne S. Mirra, Ann M. Saunders, Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease Relation of Histologic Markers to Dementia Severity, Age, Sex, and Apolipoprotein E Genotype JAMA Neurology. ,vol. 55, pp. 326- 335 ,(1998) , 10.1001/ARCHNEUR.55.3.326
Christian Haass, Dennis J. Selkoe, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide Nature Reviews Molecular Cell Biology. ,vol. 8, pp. 101- 112 ,(2007) , 10.1038/NRM2101
Marcin Misztal, Tadeusz Frankiewicz, Chris G. Parsons, Wojciech Danysz, Learning deficits induced by chronic intraventricular infusion of quinolinic acid — protection by MK-801 and memantine European Journal of Pharmacology. ,vol. 296, pp. 1- 8 ,(1996) , 10.1016/0014-2999(95)00682-6